Different antibiotic susceptibility between antrum and corpus of the stomach, a possible reason for treatment failure of Helicobacter pylori infection

World Journal of Gastroenterology

Volumn 20, Issue 43, 2014, Pages 16245-16251

  Selgrad, Michael ^a   Tammer, Ina ^a   Langner, Cosima ^a   Bornschein, Jan ^a   Meible, Julia ^a   Kandulski, Arne ^a   Varbanova, Mariya ^a   Wex, Thomas ^a   Schlüter, Dirk ^a   Malfertheiner, Peter ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Antibiotic susceptibility; Helicobacter pylori treatment; Heteroresistance

Indexed keywords

AGAR; AMOXICILLIN; CLARITHROMYCIN; DNA; LEVOFLOXACIN; METRONIDAZOLE; RIFABUTIN; TETRACYCLINE; ANTIINFECTIVE AGENT; BACTERIAL DNA;

ADULT; AGAR DIFFUSION; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATION; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; DNA DETERMINATION; DNA FINGERPRINTING; DRUG TREATMENT FAILURE; EPSILOMETER TEST; ERADICATION THERAPY; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; RANDOM AMPLIFIED POLYMORPHIC DNA; STOMACH; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH CORPUS; TREATMENT INDICATION; AGED; COMPARATIVE STUDY; DRUG EFFECTS; DUODENOSCOPY; GASTROSCOPY; GENETICS; GENOTYPE; GERMANY; HELICOBACTER INFECTIONS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; PREDICTIVE VALUE; RETROSPECTIVE STUDY;

ADULT; AGED; ANTI-BACTERIAL AGENTS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DUODENOSCOPY; FEMALE; GASTROSCOPY; GENOTYPE; GERMANY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PYLORIC ANTRUM; RETROSPECTIVE STUDIES;

EID: 84912527388     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i43.16245     Document Type: Article

References (25)

1. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ. Management of Helicobacter pylori infection-the Maastricht IV/Florence Consensus Report. Gut 2012; 61: 646-664 [PMID: 22491499 DOI: 10.1136/gutjnl-2012-302084].
2. Malfertheiner P, Chan FK, McColl KE. Peptic ulcer disease. Lancet 2009; 374: 1449-1461 [PMID: 19683340 DOI: 10.1016/S0140-6736(09)60938-7].
3. Selgrad M, Malfertheiner P. Treatment of Helicobacter pylori. Curr Opin Gastroenterol 2011; 27: 565-570 [PMID: 21946029 DOI: 10.1097/MOG.0b013e32834bb818].
4. Megraud F, Coenen S, Versporten A, Kist M, Lopez-Brea M, Hirschl AM, Andersen LP, Goossens H, Glupczynski Y. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 2013; 62: 34-42 [PMID: 22580412 DOI: 10.1136/gutjnl-2012-302254].
5. Asaka M, Kato M, Takahashi S, Fukuda Y, Sugiyama T, Ota H, Uemura N, Murakami K, Satoh K, Sugano K. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter 2010; 15: 1-20 [PMID: 20302585 DOI: 10.1111/j.1523-5378.2009.00738.x].
6. Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, Lam SK, Xiao SD, Tan HJ, Wu CY, Jung HC, Hoang BH, Kachintorn U, Goh KL, Chiba T, Rani AA. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol 2009; 24: 1587-1600 [PMID: 19788600 DOI: 10.1111/j.1440-1746.2009.05982.x].
7. Fischbach W, Malfertheiner P, Hoffmann JC, Bolten W, Bornschein J, Götze O, Höhne W, Kist M, Koletzko S, Labenz J, Layer P, Miehlke S, Morgner A, Peitz U, Preiss J, Prinz C, Rosien U, Schmidt W, Schwarzer A, Suerbaum S, Timmer A, Treiber G, Vieth M. S3-guideline "helicobacter pylori and gastroduodenal ulcer disease" of the German society for digestive and metabolic diseases (DGVS) in cooperation with the German society for hygiene and microbiology, society for pediatric gastroenterology and nutrition e. V., German society for rheumatology, AWMF-registration-no. 021/001. Z Gastroenterol 2009; 47: 1230-1263 [PMID: 19960402 DOI: 10.1055/s-0028-1109855].
8. Goodwin CS, Worsley BW. Microbiology of Helicobacter pylori. Gastroenterol Clin North Am 1993; 22: 5-19 [PMID: 8449570].
9. Bayerdörffer E, Oertel H, Lehn N, Kasper G, Mannes GA, Sauerbruch T, Stolte M. Topographic association between active gastritis and Campylobacter pylori colonisation. J Clin Pathol 1989; 42: 834-839 [PMID: 2768523 DOI: 10.1136/jcp.42.8.834].
10. Kim JJ, Kim JG, Kwon DH. Mixed-infection of antibiotic susceptible and resistant Helicobacter pylori isolates in a single patient and underestimation of antimicrobial susceptibility testing. Helicobacter 2003; 8: 202-206 [PMID: 12752732 DOI: 10.1046/j.1523-5378.2003.00145.x].
11. Mégraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev 2007; 20: 280-322 [PMID: 17428887 DOI: 10.1128/CMR.00033-06].
12. Wueppenhorst N, Stueger HP, Kist M, Glocker E. Identification and molecular characterization of triple- And quadrupleresistant Helicobacter pylori clinical isolates in Germany. J Antimicrob Chemother 2009; 63: 648-653 [PMID: 19190100 DOI: 10.1093/jac/dkp003].
13. Cederbrant G, Kahlmeter G, Ljungh A. The E test for antimicrobial susceptibility testing of Helicobacter pylori. J Antimicrob Chemother 1993; 31: 65-71 [PMID: 8444676 DOI: 10.1093/jac/31.1.65].
14. Glupczynski Y, Labbé M, Hansen W, Crokaert F, Yourassowsky E. Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori. J Clin Microbiol 1991; 29: 2072-2075 [PMID: 1774337].
15. Ayala G, Galván-Portillo M, Chihu L, Fierros G, Sánchez A, Carrillo B, Román A, López-Carrillo L, Silva-Sánchez J. Resistance to antibiotics and characterization of Helicobacter pylori strains isolated from antrum and body from adults in Mexico. Microb Drug Resist 2011; 17: 149-155 [PMID: 21303219 DOI: 10.1089/mdr.2010.0154].
16. Rimbara E, Noguchi N, Tanabe M, Kawai T, Matsumoto Y, Sasatsu M. Susceptibilities to clarithromycin, amoxycillin and metronidazole of Helicobacter pylori isolates from the antrum and corpus in Tokyo, Japan, 1995-2001. Clin Microbiol Infect 2005; 11: 307-311 [PMID: 15760428 DOI: 10.1111/j.1469-0691.2005.01099.x].
17. Yousfi MM, Reddy R, Osato MS, Graham DY. Is antrum or corpus the best site for culture of Helicobacter pylori? Helicobacter 1996; 1: 88-91 [PMID: 9398884 DOI: 10.1111/j.1523-5378.1996.tb00016.x].
18. Selgrad M, Bornschein J, Malfertheiner P. Guidelines for treatment of Helicobacter pylori in the East and West. Expert Rev Anti Infect Ther 2011; 9: 581-588 [PMID: 21819326 DOI: 10.1586/eri.11.80].
19. Malfertheiner P, Bazzoli F, Delchier JC, Celiñski K, Giguère M, Rivière M, Mégraud F. Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: A randomised, openlabel, non-inferiority, phase 3 trial. Lancet 2011; 377: 905-913 [PMID: 21345487 DOI: 10.1016/S0140-6736(11)60020-2].
20. Gisbert JP, Castro-Fernandez M, Perez-Aisa A, Cosme A, Molina-Infante J, Rodrigo L, Modolell I, Cabriada JL, Gisbert JL, Lamas E, Marcos E, Calvet X. Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures. Aliment Pharmacol Ther 2012; 35: 941-947 [PMID: 22372560].
21. Marzio L, Cellini L, Amitrano M, Grande R, Serio M, Cappello G, Grossi L. Helicobacter pylori isolates from proximal and distal stomach of patients never treated and already treated show genetic variability and discordant antibiotic resistance. Eur J Gastroenterol Hepatol 2011; 23: 467-472 [PMID: 21537122 DOI: 10.1097/MEG.0b013e328345d40f].
22. Karczewska E, Wojtas-Bonior I, Sito E, Zwolinska-Wcisło M, Budak A. Primary and secondary clarithromycin, metronidazole, amoxicillin and levofloxacin resistance to Helicobacter pylori in southern Poland. Pharmacol Rep 2011; 63: 799-807 [PMID: 21857091 DOI: 10.1016/S1734-1140(11)70592-8].
23. Raymond J, Lamarque D, Kalach N, Chaussade S, Burucoa C. High level of antimicrobial resistance in French Helicobacter pylori isolates. Helicobacter 2010; 15: 21-27 [PMID: 20302586].
24. Wolle K, Leodolter A, Malfertheiner P, König W. Antibiotic susceptibility of Helicobacter pylori in Germany: Stable primary resistance from 1995 to 2000. J Med Microbiol 2002; 51: 705-709 [PMID: 12171304].
25. Torres A, Liapikou A. Levofloxacin for the treatment of respiratory tract infections. Expert Opin Pharmacother 2012; 13: 1203-1212 [PMID: 22594848 DOI: 10.1517/14656566.2012.688 952].